ImmuCell Corporation Proceeds from (Repayments of) Other Debt
ImmuCell Corporation (ICCC) reported Proceeds from (Repayments of) Other Debt of -$19.31 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherDebt · last filed 2023-08-10
- ImmuCell Corporation proceeds from (repayments of) other debt for the quarter ending 2022-12-31 was $0.00.
- ImmuCell Corporation proceeds from (repayments of) other debt for the quarter ending 2022-09-30 was $0.00.
- ImmuCell Corporation proceeds from (repayments of) other debt for the quarter ending 2022-06-30 was -$480.00.
- ImmuCell Corporation proceeds from (repayments of) other debt for the quarter ending 2022-03-31 was -$18.83K.
- ImmuCell Corporation proceeds from (repayments of) other debt for fiscal 2022 was -$19.31K, a 949.74% decline from fiscal 2021.
- ImmuCell Corporation proceeds from (repayments of) other debt for fiscal 2021 was $2.27K.
| Period end | Proceeds from (Repayments of) Other Debt 3 month | Proceeds from (Repayments of) Other Debt 6 month | Proceeds from (Repayments of) Other Debt 9 month | Proceeds from (Repayments of) Other Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | -$480.00 derived: sum of 3 quarters · filed 2023-08-10 | -$19.31K 10-K · filed 2023-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | -$480.00 derived: sum of 2 quarters · filed 2023-08-10 | -$19.31K 10-Q · filed 2022-11-21 | -$19.31K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-06-30 | -$480.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$19.31K 10-Q · filed 2023-08-10 | -$19.31K derived: sum of 3 quarters · filed 2023-08-10 | -$19.31K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$18.83K 10-Q · filed 2023-05-11 | -$18.83K derived: sum of 2 quarters · filed 2023-05-11 | -$18.83K derived: sum of 3 quarters · filed 2023-05-11 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 derived: sum of 2 quarters · filed 2023-03-29 | $2.27K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $2.27K 10-Q · filed 2022-11-21 | ||
| 2021-06-30 | $2.27K 10-Q/A · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |